Ribavirin priming pegylated-Interferon combination therapy in chronic hepatitis C patients: study of plasma Ribavirin trough concentrations, anaemia, viral kinetic and genetic variability

被引：0
|
作者：
Munoz-de-Rueda, Paloma [1 ,2 ]
Martin-Lagos, Alicia [1 ]
Quiles, Rosa [1 ,2 ]
Gila, Ana [1 ,2 ]
Belen Martin, Ana [1 ]
Pavon-Castillero, Esther-Jose [1 ]
Ruiz Escolano, Elena [1 ]
Manuel Jimenez-Ruiz, Sergio [1 ]
Ruiz-Extremera, Angeles [2 ,3 ]
Salmeron, Javier [1 ,2 ]
机构：
[1] Hosp Univ San Cecilio, Unit Clin Management Digest Tract, Granada, Spain
[2] CIBERehd, Granada, Spain
[3] Hosp Univ San Cecilio, Serv Pediat, Granada, Spain
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1932
引用
收藏
页码：1141A / 1142A
页数：2
相关论文
共 50 条
  • [31] Pegylated interferon and ribavirin in haemodialyzed patients with chronic hepatitis C:: A prospective study
    Deltenre, Pierre
    Canva, Valérie
    Provot, François
    Glowacki, François
    Dharancy, Sébastien
    Ben Ali, Houssem
    Louvet, Alexandre
    Boitard, Jeanne
    Henrion, Jean
    Noel, Christian
    Mathurin, Philippe
    HEPATOLOGY, 2006, 44 (04) : 329A - 329A
  • [32] Viral kinetics of combination pegylated interferon a-2a and ribavirin in patients with hepatitis C cirrhosis
    Gane, E
    Chapman, B
    Holland, J
    Duxfield, J
    Shi, G
    Cornelius, D
    Bain, H
    JOURNAL OF HEPATOLOGY, 2002, 36 : 107 - 107
  • [33] Pegylated interferon with ribavirin therapy for chronic infection with the hepatitis C virus
    Foster, GR
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (05) : 685 - 691
  • [34] Interferon and Ribavirin combination therapy in chronic hepatitis C: Predictors of sustained viral response
    Osowo, AT
    Jeevanantham, V
    Kothari, T
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S112 - S113
  • [35] Mutagenic effects of ribavirin and response to interferon/ribavirin combination therapy in chronic hepatitis C
    Asahina, Y
    Izumi, N
    Enomoto, N
    Uchihara, M
    Kurosaki, M
    Onuki, Y
    Nishimura, Y
    Ueda, K
    Tsuchiya, K
    Nakanishi, H
    Kitamura, T
    Miyake, S
    JOURNAL OF HEPATOLOGY, 2005, 43 (04) : 623 - 629
  • [36] Effects of Host and virus related factors on Interferon-α plus ribavirin and Pegylated-interferon plus ribavirin treatment outcomes in Chronic Hepatitis C patients
    Akram, Madiha
    Idrees, Muhammad
    Zafar, Shamail
    Hussain, Abrar
    Butt, Sadia
    Afzal, Samia
    Rehman, Irshad-ur
    Liaqat, Ali
    Saleem, Sana
    Ali, Muhammad
    Butt, Azeem
    VIROLOGY JOURNAL, 2011, 8
  • [37] High efficacy of combination therapy with pegylated interferon and ribavirin in hemophiliacs with chronic hepatitis C.
    Mancuso, ME
    Santagostino, E
    Rumi, MG
    Linari, S
    Coppola, A
    Rocino, A
    Iorio, A
    Dragani, A
    Barillari, G
    Tagariello, G
    Nicolin, R
    Colombo, M
    Mannucci, PM
    BLOOD, 2005, 106 (11) : 899A - 900A
  • [38] Interferon-ribavirin combination therapy for chronic hepatitis C
    Schalm, SW
    Brouwer, JT
    Chemello, L
    Alberti, A
    Bellobuono, A
    Ideo, G
    Schwartz, R
    Weiland, O
    DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (12) : S131 - S134
  • [39] IMPORTANCE OF PRIOR PSYCHIATRIC CONSULTATION IN PEGYLATED INTERFERON AND RIBAVIRIN COMBINATION THERAPY FOR CHRONIC HEPATITIS C
    Kuhara, Kouichiro
    Ide, Tatsuya
    Uchimura, Naohisa
    Kumashiro, Ryukichi
    Arinaga, Teruko
    Ogata, Kei
    Kuwahara, Reiichiro
    Miyajima, Ichiro
    Sata, Michio
    HEPATOLOGY, 2008, 48 (04) : 893A - 893A
  • [40] Hemochromatosis Gene Mutations: Prevalence and Effects on Pegylated-Interferon and Ribavirin Therapy Response in Chronic Hepatitis C in Sardinia
    Sini, Margherita
    Sorbello, Orazio
    Civolani, Alberto
    Demelia, Luigi
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2012, 2 (03) : 211 - 217
12345